Aims: To investigate the influence of the A1 allele of the TAQ1A polymorphism in the dopamine D2 receptor (DRD2) gene region on mortality in adult individuals with alcohol dependence. Methods: The study sample consisted of 359 alcohol-dependent individuals treated for severe alcohol withdrawal symptoms in 1997. Years of survival was studied in an 18-year follow-up. In the analyses, gender and age were controlled for. Results: At the 18-year follow-up, 53% individuals had deceased. The analyses showed that older age (P < 0.001), male gender (P < 0.05) and carrying the A1 allele (P < 0.01) all significantly and independently contributed to shorten years of survival. Among the deceased individuals, the genotype A1+ was the only significant contributor to shorten years of survival. Conclusions: An important contribution of the present study is that in alcohol dependence the Taq1A1 allele of the DRD2 gene region is a risk factor for premature death of similar importance as the well-known risk factors of age and gender. Short Summary: We investigated the influence of A1 allele of the TAQ1A polymorphism in DRD2 receptor gene region on mortality in alcohol-dependent individuals in an 18-year follow-up. Age, gender and the A1 allele contributed to shorten years of survival. Among the deceased, the A1+ was the only contributor to shorten years of survival.
INTRODUCTION
It is well known that alcohol use disorders (AUDs) are associated with increased mortality and it has been estimated that AUDs are implicated in 5.9% of all deaths worldwide (WHO, 2014) . The increased mortality rate in individuals with AUDs is associated with male gender, older age and unemployment, and with alcohol-related medical illnesses (Feuerlein et al., 1994; Timko et al., 2006; Pavarin et al., 2015; Holst et al., 2017) . However, little is known about contribution of specific genes to the mortality in AUDs with the exception of an earlier study of ours (Berggren et al., 2010) reporting an association of the TAQ1A polymorphism (rs 1,800,497) in the dopamine D2 receptor (DRD2) gene region and mortality. Thus, alcohol-dependent individuals who were carriers of the A1 allele of this polymorphism were found to have an increased mortality rate during a 10-year follow-up period in comparison to non-carriers.
It should be noted that the TAQ1A polymorphism is actually located 10 kb downstream of the DRD2 gene in a protein-encoding region of a neighboring gene, ankyrin repeat and kinase domain containing 1, or ANKK1 (Neville et al., 2004) . Nevertheless, several studies have investigated the association between the TAQ1A polymorphism and striatal DRD2 availability. In a recent systematic review and meta-analysis it is concluded that the TAQ1A polymorphism robustly influences striatal DRD2 availability, i.e. healthy carriers of the A1 allele have lower DRD2 availability (Gluskin and Mickey, 2016) . It is also concluded that this polymorphism is likely to contribute to important differences in human striatal function, risk of neuropsychiatric diseases and alterations in pharmacological responses (Gluskin and Mickey, 2016) . Additionally, it is also of note that several large studies (comprising 500-2000 individuals) found associations between the A1 allele and poorer cognitive function, suggesting that lower DRD2 expression among A1 carriers confer poorer cognitive function (Gluskin and Mickey, 2016) .
With respect to the association between the TAQ1A polymorphism and alcohol dependence, numerous studies have been performed since the landmark study by Blum et al. (1990) . Thus, there are now several meta-analyses showing an over-representation of carriers of the A1 allele in alcohol dependent individuals (Noble, 2003; Young et al., 2004; Munafò et al., 2007; Smith et al., 2008; Wang et al., 2013) , although the odds ratio may be small,~1.2 (Munafò et al., 2007; Smith et al., 2008; Wang et al., 2013) . In a previous study of ours of 366 alcohol-dependent individuals, treated as in-patients for alcohol withdrawal symptoms, we found that~40% of these individuals were carriers of the A1 allele in comparison to~30% in healthy controls (Berggren et al., 2006) .
In this above mentioned study of ours (Berggren et al., 2006 ) the alcohol-dependent individuals were followed-up during a 10-year time period and the mortality was registered (Berggren et al., 2010) . It was found that there was an increased standardized mortality rate (~40%) in the carriers of the A1 allele compared to non-carriers of the A1 allele (Berggren et al., 2010) . Given the sparse information of the contribution of specific genes to the mortality in individuals with AUDs, the aim of the present study was therefore to extend the follow-up period to 18-year and to more thoroughly control for other factors of importance for the mortality rate (i.e. gender, age and unemployment). For the latter purposes we used multiple regression analysis and a case matching procedure in which the individuals were matched for gender and age. Years of survival was chosen as main outcome variable. The hypothesis was that carriers of the A1 allele would have fewer years of survival.
METHODOLOGY
Participants in this study were all adult patients consecutively admitted to an alcohol and drug treatment unit at the psychiatric department of a University hospital for treatment of severe alcohol withdrawal symptoms during a treatment episode in 1997 (n = 375). They had to fulfill the DSM-IV criteria for alcohol dependence (American Psychiatric Association, 1994) according to diagnoses from previous hospital records and/or assessments at time after admittance. During this treatment episode, the patients were also genotyped for the TAQ1A polymorphism of the DRD2 gene. For further description of the patients and genotyping procedure, see Berggren et al. (2006) and Berggren et al. (2010) .
Information about diagnosis of alcohol dependence, gender, age and genotype was obtained from hospital records during the treatment episode in 1997. The remaining variables used in this study were retrieved from high-quality national registers using the unique 10-digit identification numbers given to all Swedish residents at birth or immigration. Registry data for the all 375 individuals was requested, but due to lack of information about the 10-digit identification numbers or because they had moved abroad, data for 16 individuals were missing from the registers. Thus in total, data from 359 alcohol dependent individuals who were followed-up could be used. Registry data were retrieved from the following national register holders: the National Board of Health and Welfare and the Statistics Sweden. Background data (civil status, education, employment and income) of the year of 1997 was retrieved from the Statistics Sweden. The outcome variable regarding number of deaths between the years 1997-2015 was retrieved from the National Cause of Death Register (held by the National Board of Health and Welfare), which covers all registered deaths in Sweden.
Regarding background data of the year of 1997, comparisons were made between individuals carrying genotype A1+ (i.e. genotypes A1/A1 or A1/A2) and A1− (i.e. genotype A2/A2). Comparisons were also made between deceased and living individuals regarding the prevalence of genotype (i.e. A1+ and A1−) and background data using Student's t-test or χ 2 test. Moreover, comparisons between male A1+, female A1+, male A1− and female A1− in years of survival were performed by using ANOVA. The variable years of survival was created for those who had died as the difference between the year of death and the year of admittance to the alcohol and drug treatment unit (treatment episode during 1997). For those who still were alive after 18 years the years of survival was set to 18 years. In addition, a hierarchical multiple regression analysis was performed, where years of survival was the dependent variable and genotype (i.e. A1+ and A1−), gender and age were the independent variables. Furthermore, using a case-control matching function (in SPSS v24), patients with the genotype A1+ (n = 140 'active') were matched 1:1 with patients with the genotype A1− ('control') on the basis of gender and age. Both groups comprised of 24 women and 116 men and their mean ages in 1997 were 47.6 and 47.4 years, respectively. For no matched pair was the difference in years between active and controls larger than 2 years. Finally, to further elucidate the relative contribution of the Taq1A1 allele of the DRD2 gene (region) to years of survival among the deceased individuals we apart from age and gender also incorporated ICD-10 causes of death in an extended hierarchical multiple regression P-values of <0.05 were considered statistically significant. For all statistical analyses, SPSS v24 (IBM SPSS Statistics, IBM Corporation, Chicago, IL) was used. The Regional Ethical Review Board in Gothenburg approved the study, including the data linkage (# 094-14) .
RESULTS
In total, 375 alcohol-dependent individuals, consecutively admitted for treatment of alcohol withdrawal syndromes during 1997 were included in the study. At the follow-up, data for 16 individuals were missing in the national registers. The study sample eligible for follow-up thus comprised of 359 alcohol-dependent individuals, 66 females (18%) and 293 males (82%). One hundred and forty (39%) were carriers of the genotype A1+ and 219 (61%) were carriers of the genotype A1−. As seen in Table 1 , there was no differences in the background data for individuals carrying the genotype A1+ and the A1−.
Mortality at 18-year follow-up
At the follow-up 192 of the 359 individuals were deceased. Their mean age at death was 58.4 ± 11.6 years. Thus, the overall mortality for the 18-year follow-up period was 53% and significantly more males than females were deceased (57.5 vs. 34.4%; P = 0.001, χ 2 = 10.87). As seen in Table 2 , individuals who had deceased during the 18 years follow-up period were in 1997 in average 5 years older (49.7 ± 10.4 vs. 44.7 ± 10.1 years; P < 0.001, t = 4.5). Otherwise, there were no differences in the background variables 1997. However, those who were deceased were more frequently, although non-significantly (P = 0.08), carriers of the genotype A1+ in comparison to those who were living at the follow-up (Table 2) . To evaluate the influence of age, gender and genotype (A1+ vs. A1−) on the mortality a hierarchical multiple regression model was used. In this model years of survival was the dependent variable and age, gender and genotype were independent variables. This model showed that older age (P < 0.001), male gender (P < 0.05) and genotype A1+ (P < 0.01) all significantly and independently contributed to shorten years of survival during the follow-up period. These three variables contributed to 6.4% (based of the sum of the R 2 values) of the total variance (Table 3) .
To further explore the impact of the genotype A1+ on years of survival, carriers of the genotypes A1+ and A1− were matched for age and gender. Years of survival was thereafter calculated and compared between the genotype groups. It was found that the carriers of the genotype A1+ had fewer years of survival of~2 years during the 18-year follow-up period (genotype A1+ 11.5 ± 5.8 vs. genotype A1-13.6 ± 5.0 years; P = 0.001), see Table 4 .
Finally, in an attempt to compare years of survival due to genotype with that of gender, the years of survival was calculated for male A1+, female A1+, male A1− and female A1− individuals. As seen in Table 5 , male carriers of the A1+ genotype had the shortest time of survival whereas females who were non-carriers of this genotype had the longest time of survival during the 18-year follow-up period (P < 0.01).
Underlying causes of death during the 18-year follow up
For the total sample, the five leading underlying causes of death according to ICD-10 (comprising 89% of all causes) were in declining order: accidents V01-X59 (25%), diseases of the circulatory system I00-I99 (23%), mental and behavior disorders, i.e. alcohol dependence syndrome F10.2 (21%), diseases of the digestive system K00-K93 (11%) and neoplasms C00-D48 (9%). There were no significant differences in causes of death between the carriers of genotypes A1+ and A1−. To elucidate the relative contribution of the Taq1A1 allele of the DRD2 gene (region) to years of survival among the deceased individuals we, apart from age and gender, also incorporated the five most common ICD-10 causes of death in an extended hierarchical multiple regression. This analysis showed that the only significant contributor for years of survival, among the deceased individuals, was the genotype A1+ (P < 0.01). Based on the R 2 values this variable explained almost 2% of the variance (Table 6) .
DISCUSSION
In the present study we found that TAQ1A1 allele located in the DRD2 gene region was associated with a reduction in years of survival 47.6 ± 10.1 47.4 ± 10.9 ns Years of survival 11.5 ± 5.8 13.6 ± 5.0 0.001 in 359 alcohol dependent individuals followed-up during 18 years. This study is an extension of an earlier study of ours (Berggren et al., 2010) in which we found an increased mortality rate in carriers of the genotype A1+ during a follow-up period of 10 years. Apart from extending the follow-up period to 18 years, in this study we also controlled for other factors that may influence the mortality rate and years of survival in alcohol dependent individuals. We thus found a significant influence of gender and age on the years of survival at the 18-year follow-up. More specific, male gender and older age (at 1997) were associated with shortening of years of survival, findings in accordance with several previous studies (Feuerlein et al., 1994; Timko et al., 2006; Pavarin et al., 2015) . However, when controlling for these factors, by using a logistic regression analysis and also a matching procedure, there was still an independent influence of the genotype A1+. Thus, carriers of the genotype A1+ had a reduction of 1.6 years of survival during the 18 years follow-up period. In addition, no differences in underlying causes of death between the genotypes A1+ and A1− were observed in the present study.
From the results in this study, it can be estimated that carrying the genotype A1+ shorten years of survival in alcohol-dependent individuals with~10% during an 18 years follow-up period. This figure is very similar to that of male gender, which also shorten years of survival with 1.6 years. Therefore, not surprisingly, the combination of carrying the genotype A1+ and being of male gender caused the most pronounced reduction of years of survival, followed by being of female gender carrying the A1 allele.
It is also noteworthy that when the relative contribution of the genotype A1+ to years of survival among the deceased individuals was evaluated in an extended hierarchical multiple regression analysis which, apart from age and gender, also included the five most common ICD-10 causes of death in this study, the genotype A1+ was the only significant contributor. This finding further strengthens the association of genotype A1+ and premature death in alcohol dependent individuals.
The reason for why alcohol-dependent individuals, carrying the genotype A1+, have shortened years of survival is still unclear. However, there are studies showing that carriers of the A1 allele have an earlier onset of problem drinking and consume larger amounts of alcohol (Connor et al., 2002 (Connor et al., , 2008 ; see also Panduro et al., 2017) . One possibility for these drinking behaviors may be that carriers of the A1 allele compensate for the reduced number of dopamine D2 receptors by using larger amount of alcohol to increase the presynaptic release of dopamine (Noble, 2003; Heinz et al., 2009; Volkow et al., 2017) . Thus, carriers of the A1 allele may have to use larger amounts of alcohol in order to compensate for the dopamine deficiency in comparison to their counterparts who are carriers of the genotype A1−. Another possibility, as shown in healthy individuals by Gluskin and Mickey (2016) is that carriers of the A1 allele may have poorer cognitive functions. For example, Jocham et al. (2009) have shown that healthy individuals carrying the A1 allele had impaired reversal learning. It may therefore be hypothesized that alcoholdependent individuals carrying the A1 allele drink more excessively due to such cognitive deficits hampering their ability to control or reduce their alcohol consumption. Finally, it is also of note that Richter et al. (2017) found relatively better memory for rewarded stimuli in healthy carriers of the A1 allele. Alcohol-dependent individuals who are carriers of the A1 allele may thus drink alcohol more excessively due to their enhanced memory for rewarded stimuli.
The more excessive drinking behavior in carriers of the A1 allele may result in more severe alcohol-related medical complications (Feuerlein et al., 1994; Timko et al., 2006; Pavarin et al., 2015; Holst et al., 2017) . Indeed, we have earlier found that the carriers of the A1 allele, already at the start of the follow-up in 1997, had a history of more severe somatic and psychiatric disorders (Berggren et al., 2006) . It is well known that alcohol-dependence and concomitant comorbidity (particularly more severe alcohol-related somatic disorders) increases the risk for premature death (Feuerlein et al., 1994; Holst et al., 2017) , which may explain the shortening of years of survival in the carriers of the A1 allele in the present study.
There are some limitations in the present study that ought to be mentioned. The cause of death from alcohol dependence is not captured solely by genotype, gender and age, and the picture is far more complex. For example, the individuals in this study were not assessed for tobacco use and it cannot be ruled out that the difference in mortality rate between the groups can be due to difference in tobacco use. Furthermore, the increased mortality rate in the carriers of the A1 allele can be due to other factors. For example, earlier onset of problem drinking and consumption of larger amounts of alcohol in the carriers of the A1 allele, as found in the earlier mentioned studies by Connor et al. (2002 and , may have contributed to the shortening of years of survival in the A1+ individuals in the present study. In our first study of the present group of alcohol (Berggren et al., 2006 ) the assessment performed at the treatment period in 1997 could be considered as baseline values for the present study. There was, however, no differences neither in duration (years) of alcohol dependence, nor in biochemical assessment of alcohol consumption before entering treatment, i.e. serum carbohydrate deficient transferrin between the genotype groups. Furthermore, there was no difference in the liver function test (AST, ALT, G-GT). These findings argues against a difference between the genotype groups in alcohol consumption at least at baseline. Despite these limitations, an important contribution of the present study is that in alcohol dependence, the Taq1A1 allele of the DRD2 gene region is a risk factor for premature death of similar importance as the well-known risk factors of age and gender. If replicated, this finding may have clinical implications with regard to assessment and treatment of AUDs.
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